The EMA Management Board's September 2026 meeting provided a mid-year report on operational results and achievements. Specific details on drug approvals or designations were not disclosed.
Mid-year report 2026 from the Executive DirectorEMA presented results and achievements of its operations for the first half of 2026 to the Management Board. Between January and…
Original title: “EMA Management Board: highlights of September 2026 meeting”